PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
02-Aug-2022 Immutep Reports new positive interim data from its Phase II Study of LAG-3 candidate, Eftilagimod Alpha, in second-line PD-X refractory NSCLC Immutep
02-Aug-2022 HUTCHMED Initiates a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China HUTCHMED
01-Aug-2022 ViiV Healthcare presents positive five-year data at AIDS 2022, demonstrating the durability of fostemsavir in people living with HIV who are heavily treatment-experienced ViiV Healthcare
26-Jul-2022 SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab) SOTIO
25-Jul-2022 Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022" Novotech Health Holdings Pte Ltd
22-Jul-2022 Personalized Nutrition Market Business Growth Analysis from 2019 - 2028 Axiom Market Research & Consulting
22-Jul-2022 uMotif expands leadership team to support growth in US and EU markets uMotif
22-Jul-2022 Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Takeda
21-Jul-2022 F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody F-star Therapeutics
21-Jul-2022 Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing Navigo Proteins GmbH
20-Jul-2022 A new measure of psychological safety for patients University of Strathclyde
20-Jul-2022 ALLIANCE PHARMA Half Year Trading Update ALLIANCE PHARMA
20-Jul-2022 Almirall launches new call to find innovative therapies for skin diseases Almirall
20-Jul-2022 Resolution Therapeutics Appoints Dr. Bill Symonds to its Board of Directors Resolution Therapeutics
19-Jul-2022 AARDEX® Group and BIOCORP Recruited by Trials@Home - Decentralized Clinical Trial Centre of Excellence AARDEX® Group
19-Jul-2022 Bone Therapeutics optimizes statistical analysis and introduces interim analysis in the ongoing ALLOB Phase IIb study for high-risk tibial fractures Bone Therapeutics
19-Jul-2022 Destiny Pharma announces positive update from US FDA on XF-73 Phase 3 development plans Destiny Pharma
18-Jul-2022 Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T" Novotech Health Holdings Pte Ltd
18-Jul-2022 TrialWire Technology Platform Announces Success-based Patient Recruitment Plan TrialWire
15-Jul-2022 Growing Elderly Population Leads to Benign Prostatic Hyperplasia Treatment Market Expansion P&S Intelligence